The DOI matches its Crossref record; 151 of the 153 references it cites were found in a registry or an index.
Intracellular amyloid-β in Alzheimer's disease
Abstract
The primal role that the amyloid-beta (Abeta) peptide has in the development of Alzheimer's disease is now almost universally accepted. It is also well recognized that Abeta exists in multiple assembly states, which have different physiological or pathophysiological effects. Although the classical view is that Abeta is deposited extracellularly, emerging evidence from transgenic mice and human patients indicates that this peptide can also accumulate intraneuronally, which may contribute to disease progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“verified that plaque deposition requires BACE1 activity, as previously shown [17-20].”
From Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation (2013) · cites this paper as [17]
In the citing paper
“In PD, intracellular inclusions of alpha-synuclein (αSYN) are found in neurons and glia, while both extracellular and intracellular deposits of amyloid-beta (Aβ) are present in the AD brain [2, 3].”
From Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates (2021) · cites this paper as [3]
In the citing paper
“A accumulation occurs prior to extracellular amyloid formation, has been implicated in the onset of early cognitive alterations, and may contribute to the pathological cascade of events that leads to neuronal dysfunction and, eventually, to AD (12,13).”
From Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4 (2014) · cites this paper as [12]
In the citing paper
“Furthermore, the 42-amino acid A (A42) constitutes the majority of intraneuronal A (12).”
From Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4 (2014) · cites this paper as [12]
In the citing paper
“Accumulation of A, the majority of which is A42, occurs prior to extracellular amyloid formation, has been implicated in the onset of early cognitive alterations, and may contribute to the pathological cascade of events that lead to neuronal dysfunction and, eventually, to AD (12,13).”
From Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4 (2014) · cites this paper as [12]
In the citing paper
“Since accumulation of Aβ42 within AD vulnerable neurons has been associated with physiological, pathological and behavioral abnormalities even prior to plaques [12, 140, 187, 188], the evidence is mounting that intraneuronal Aβ42 is the driving force in Aβ-related AD pathogenesis [9, 58, 92].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [92]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Self-citationVassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Flagged first, then by citations
2 of the 153 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 1,005
The effects of exercise on hypothalamic neurodegeneration of Alzheimer’s disease mouse model
Do, K., Laing, B. T., Landry, T., Bunner, W., Mersaud, N., Matsubara, T., Li, P.-X., Yuan, Y., Lu, Q., & Hu, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190205 · Cited by 82
Völgyi, K., Badics, K., Sialana, F. J., Gulyássy, P., Udvari, E. B., Kis, V., Drahos, L., Lübec, G., Kékesi, K. A., & Juhász, G. D. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0955-6 · Cited by 80
Neurovascular Inflammaging in Health and Disease
Mészáros, Á., Molnár, K., Nógrádi, B., Hernádi, Z., Nyúl‐Tóth, Á., Wilhelm, I., & Krizbai, I. A. (2020) · Cells · doi:10.3390/cells9071614 · Cited by 86
Kaur, G., Rathod, S. S. S., Ghoneim, M. M., Alshehri, S., Ahmad, J., Mishra, A., & Alhakamy, N. A. (2022) · Biology · doi:10.3390/biology11010090 · Cited by 79
Bee venom ameliorates lipopolysaccharide-induced memory loss by preventing NF-kappaB pathway
Gu, S. M., Park, M. H., Hwang, C. J., Song, H. S., Lee, U. S., Han, S., Oh, K. W., Ham, Y. W., Song, M. J., Son, D. J., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0344-2 · Cited by 78
Intracellular amyloid beta alters the tight junction of retinal pigment epithelium in 5XFAD mice
Park, S. W., Kim, J. H., Mook‐Jung, I., Kim, K.-W., Park, W. J., Park, K. H., & Kim, J. H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.008 · Cited by 78
Askanas, V., & Engel, W. K. (2011) · La Presse Médicale · doi:10.1016/j.lpm.2010.11.024 · Cited by 78
Grabrucker, A. M., Schmeißer, M. J., Udvardi, P. T., Arons, M. H., Schoen, M., Woodling, N. S., Andreasson, K. I., Hof, P. R., Buxbaum, J. D., Garner, C. C., et al. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-65 · Cited by 77
Towards Understanding the Roles of Heparan Sulfate Proteoglycans in Alzheimer’s Disease
Zhang, G.-L., Zhang, X., Wang, X., & Li, J. (2014) · BioMed Research International · doi:10.1155/2014/516028 · Cited by 80
Bhattarai, P., Thomas, A. K., Zhang, Y., & Kızıl, Ç. (2017) · Neurogenesis · doi:10.1080/23262133.2017.1322666 · Cited by 80
Mondragón‐Rodríguez, S., Salas-Gallardo, A., González-Pereyra, P., Macías, M., Ordaz, B., Peña‐Ortega, F., Aguilar-Vázquez, A. R., Orta‐Salazar, E., Díaz-Cintra, S. Y., Perry, G. L., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001187 · Cited by 77
Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)
Probst, G. D., & Xu, Y. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.681302 · Cited by 76
Lista, S., Garaci, F., Ewers, M., Teipel, S. J., Zetterberg, H., Blennow, K., & Hampel, H. J. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.04.506 · Cited by 78
Vascular pathology: Cause or effect in Alzheimer disease?
Rius‐Pérez, S., Tormos, A. M., Pérez, S., & Taléns‐Visconti, R. (2017) · Neurología (English Edition) · doi:10.1016/j.nrleng.2015.07.008 · Cited by 79
Colombo, A., Wang, H., Kuhn, P.-H., Page, R., Kremmer, E., Dempsey, P. J., Crawford, H. C., & Lichtenthaler, S. F. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.08.011 · Cited by 62
Ogi, H. (2013) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.89.401 · Cited by 78
Scott, P. J. H., Hockley, B. G., Kung, H. F., Manchanda, R., Zhang, W., & Kilbourn, M. R. (2008) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2008.08.015 · Cited by 76
Kitiyanant, N., Kitiyanant, Y., Svendsen, C. N., & Thangnipon, W. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0592-1 · Cited by 76
Role of HIV in Amyloid Metabolism
Ortega, M., & Ances, B. M. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9546-0 · Cited by 78
Kumar, S., Morton, H., Sawant, N., Orlov, E., Bunquin, L. E., Pradeepkiran, J. A., Alvir, R., & Reddy, P. H. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102182 · Cited by 75
Current pharmacotherapy and putative disease-modifying therapy for Alzheimer’s disease
Kulshreshtha, A., & Piplani, P. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2625-7 · Cited by 76
Yang, L., Sun, J., Xie, W., Liu, Y., & Liu, J. (2017) · Journal of Materials Chemistry B · doi:10.1039/c6tb02952c · Cited by 76
Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?
Potenza, M. A., Sgarra, L., Desantis, V., Nacci, C., & Montagnani, M. (2021) · Antioxidants · doi:10.3390/antiox10081257 · Cited by 78
Martemucci, G., Fracchiolla, G., Muraglia, M., Tardugno, R., Dibenedetto, R. S., & D‘Alessandro, A. G. (2023) · Antioxidants · doi:10.3390/antiox12122091 · Cited by 89
Lee, E. H., & Seo, S. R. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.7.086 · Cited by 75
Uversky, V. N. (2010) · Chemical Reviews · doi:10.1021/cr100186d · Cited by 75
Drago, D., Cavaliere, A., Mascetra, N., Ciavardelli, D., Ilio, C. D., Zatta, P. F., & Sensi, S. L. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0761 · Cited by 74
Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product?
Sutherland, G. T., Chami, B., Youssef, P., & Witting, P. K. (2013) · Redox Report · doi:10.1179/1351000213y.0000000052 · Cited by 80
Majd, S., Power, J. H. T., & Grantham, H. J. M. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0211-1 · Cited by 79
Vashist, S., Cushman-Nick, M., & Shorter, J. (2010) · Biochemistry and Cell Biology · doi:10.1139/o09-121 · Cited by 76
Tam, J. H. K., Seah, C., & Pasternak, S. (2014) · Molecular Brain · doi:10.1186/s13041-014-0054-1 · Cited by 83
Melatonin as a mitochondrial protector in neurodegenerative diseases
Wongprayoon, P., & Govitrapong, P. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2614-x · Cited by 76
Bandara, N., Sharma, A. K., Krieger, S., Schultz, J. W., Han, B. H., Rogers, B. E., & Mirica, L. M. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05937 · Cited by 82
Ciccone, R., Franco, C., Piccialli, I., Boscia, F., Casamassa, A., de Rosa, V., Cepparulo, P., Cataldi, M., Annunziato, L., & Pannaccione, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-50018-1 · Cited by 78
Li, M., Ji, J., Zheng, L.-J., Shen, J., Li, X., Zhang, Q., Bai, X., & Wang, Q. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.239449 · Cited by 74
Poon, C. H., Wang, Y., Fung, M., Zhang, C., & Lim, L. W. (2020) · Aging and Disease · doi:10.14336/ad.2019.1026 · Cited by 76
ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer’s Disease
Patro, S., Ratna, S., Yamamoto, H. A., Ebenezer, A. T., Ferguson, D. S., Kaur, A., McIntyre, B. C., Snow, R., & Solesio, M. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011185 · Cited by 76
Current perspectives on pharmacotherapy of Alzheimer's disease
Chopra, K., Misra, S., & Kuhad, A. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.520702 · Cited by 75
Increased Hippocampal Excitability in the 3xTgAD Mouse Model for Alzheimer's Disease In Vivo
Davis, K. E., Fox, S., & Gigg, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091203 · Cited by 72
Iijima‐Ando, K., Hearn, S., Granger, L., Shenton, C., Gatt, A., Chiang, H., Hakker, I., Zhong, Y., & Iijima, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710509200 · Cited by 76
Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40
Suire, C. N., Abdul-Hay, S. O., Sahara, T., Kang, D., Brizuela, M. K., Saftig, P., Dickson, D. W., Rosenberry, T. L., & Leissring, M. A. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00649-8 · Cited by 73
The role of synaptic microRNAs in Alzheimer's disease
Kumar, S., & Reddy, P. H. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165937 · Cited by 73
Vandendriessche, C., Bruggeman, A., Cauwenberghe, C. V., & Vandenbroucke, R. E. (2020) · Cells · doi:10.3390/cells9112485 · Cited by 75
The role of amyloids in Alzheimer's and Parkinson's diseases
Salahuddin, P., Fatima, M. T., Uversky, V. N., Khan, R. H., Islam, Z., & Furkan, M. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.08.197 · Cited by 74
WNT5A Signaling Contributes to Aβ-Induced Neuroinflammation and Neurotoxicity
Li, B., Zhong, L., Yang, X., Andersson, T., Huang, M., & Tang, S.-J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022920 · Cited by 81
Calkins, M. J., Mańczak, M., & Reddy, P. (2012) · Pharmaceuticals · doi:10.3390/ph5101103 · Cited by 71
Common Features at the Start of the Neurodegeneration Cascade
Hervás, R., Oroz, J., Galera‐Prat, A., Goñi, O., Valbuena, A., Vera, A. M., Gómez‐Sicilia, À., Losada-Urzáiz, F., Uversky, V. N., Menéndez, M., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001335 · Cited by 72
Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders
Reddy, A. P., Ravichandran, J., & Carkaci‐Salli, N. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.06.020 · Cited by 71
Park, H.-H., Lee, K.-Y., Kim, S., Lee, J. W., Choi, N.-Y., Lee, E.-H., Lee, Y. J., Lee, S.-H., & Koh, S.-H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.015 · Cited by 72
Askanas, V., Engel, W. K., & Nogalska, A. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31826183c8 · Cited by 74
Fecal Fungal Dysbiosis in Chinese Patients With Alzheimer’s Disease
Ling, Z., Zhu, M., Liu, X., Shao, L., Cheng, Y., Yan, X., Jiang, R., & Wu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.631460 · Cited by 72
Therapy for Alzheimer’s disease: Missing targets and functional markers?
Stoiljković, M., Horváth, T. L., & Hajós, M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101318 · Cited by 74
Ye, C. Y., Lei, Y., Tang, X. C., & Zhang, H. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.020 · Cited by 72
Blázquez, G., Cañete, T., Tobeña, A., Giménez‐Llort, L., & Fernández‐Teruel, A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.008 · Cited by 81
Dysfunction in protein clearance by the proteasome: impact on autoinflammatory diseases
Brehm, A., & Krüger, E. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0486-4 · Cited by 70
Aho, L., Pikkarainen, M., Hiltunen, M., Leinonen, V., & Alafuzoff, I. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091681 · Cited by 71
Supramolecular Exchange among Assemblies of Opposite Charge Leads to Hierarchical Structures
Wester, J. R., Lewis, J. A., Freeman, R., Sai, H., Palmer, L. C., Henrich, S. E., & Stupp, S. I. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c03529 · Cited by 71
Reduced VDAC1 Protects Against Alzheimer's Disease, Mitochondria, and Synaptic Deficiencies
Mańczak, M., Sheiko, T. V., Craigen, W. J., & Reddy, P. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130761 · Cited by 73
Hashimoto, T., Adams, K. W., Fan, Z., McLean, P. J., & Hyman, B. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257378 · Cited by 71
Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation
Du, L., & Pertsemlidis, A. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq058 · Cited by 71
Modulation of 5-Lipoxygenase in Proteotoxicity and Alzheimer's Disease
Valera, E., Dargusch, R., Maher, P. A., & Schubert, D. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5183-12.2013 · Cited by 70
Kuruva, C. S., Mańczak, M., Yin, X., Ogunmokun, G., Reddy, A. P., & Reddy, P. H. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx226 · Cited by 71
RetractedFahanik‐Babaei, J., Baluchnejadmojarad, T., Nikbakht, F., & Roghani, M. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0338-8 · Cited by 76
Tribbles Pseudokinase 3 Induces Both Apoptosis and Autophagy in Amyloid-β-induced Neuronal Death
Saleem, S., & Biswas, S. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.744730 · Cited by 70
Jellinger, K. A., Janetzky, B., Attems, J., & Kienzl, E. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00313.x · Cited by 72
Intracellular distribution of amyloid beta peptide and its relationship to the lysosomal system
Zheng, L. P., Cedazo-Mı́nguez, Á., Hallbeck, M., Jerhammar, F., Marcusson, J. O., & Terman, A. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-19 · Cited by 73
Li, F., Xi-qing, W., Li, J., & Niu, Q. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5103 · Cited by 70
Patología vascular: ¿causa o efecto en la enfermedad de Alzheimer?
Rius‐Pérez, S., Tormos, A. M., Pérez, S., & Taléns‐Visconti, R. (2015) · Neurología · doi:10.1016/j.nrl.2015.07.010 · Cited by 74
Ebrahim, N., AlSaihati, H., Alali, Z., Aleniz, F. Q., Mahmoud, S. Y., Badr, O. A. M., Dessouky, A. A., Mostafa, O., Hussien, N. I., Farid, A. S., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116836 · Cited by 69
RetractedNervous yeast: modeling neurotoxic cell death
Braun, R. J., Büttner, S., Ring, J., Kroemer, G., & Madeo, F. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.10.005 · Cited by 71
Omtri, R. S., Davidson, M. W., Arumugam, B., Poduslo, J. F., & Kandimalla, K. K. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200530q · Cited by 69
Spencer, B. J., Marr, R. A., Gindi, R., Potkar, R., Michael, S. A., Adame, A., Rockenstein, E. M., Verma, I. M., & Masliah, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016575 · Cited by 69
Kucheryavykh, L. Y., Dávila-Rodríguez, J., Rivera-Aponte, D. E., Zueva, L. V., Washington, A. V., Sanabria, P., & Inyushin, M. Y. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.11.008 · Cited by 70
Wallin, C., Hiruma, Y., Wärmländer, S. K. T. S., Huvent, I., Jarvet, J., Abrahams, J. P., Gräslund, A., Lippens, G. M., & Luo, J. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b13623 · Cited by 67
Bourgeois, A., Lauritzen, I., Lorivel, T., Bauer, C., Checler, F., & Pardossi‐Piquard, R. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.038 · Cited by 75
Armato, U., Chiarini, A., Chakravarthy, B., Chioffi, F., Pacchiana, R., Colarusso, E., Whitfield, J. F., & Dal Prà, I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.020 · Cited by 68
Le-Nhat-Thuy, G., Thị, N. N., Pham‐The, H., Thi, T. A. D., Thi, H. N., Thi, T. H. N., Hoàng, S. N., & Nguyen, T. V. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127404 · Cited by 68
Amyloid-β Peptide Is a Substrate of the Human 20S Proteasome
Zhao, X., & Yang, J. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100067e · Cited by 68
Alzheimer’s Disease: A Clinical Practice-Oriented Review
Alves, L., Correia, A. S., Miguel, R., Alegria, P., & Bugalho, P. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00063 · Cited by 74
Models of membrane‐bound Alzheimer's Abeta peptide assemblies
Shafrir, Y., Durell, S. R., Arispe, N. J., & Guy, H. R. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22853 · Cited by 69
Kim, C.-B., Choi, Y. Y., Song, W. K., & Song, K. (2013) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.5.051205 · Cited by 70
Extracellular chaperones prevent Aβ42-induced toxicity in rat brains
Cascella, R., Conti, S., Tatini, F., Evangelisti, E., Scartabelli, T., Casamenti, F., Wilson, M. R., Chiti, F., & Cecchi, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.012 · Cited by 70
Peptides as Potential Therapeutics for Alzheimer’s Disease
Ribarič, S. (2018) · Molecules · doi:10.3390/molecules23020283 · Cited by 69
Yang, X., Cai, P., Liu, Q., Wu, J., Yin, Y., Wang, X., & Kong, L. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.04.043 · Cited by 69
Revisiting the role of brain and peripheral Aβ in the pathogenesis of Alzheimer's disease
Uddin, M. S., Kabir, M. T., Tewari, D., Mamun, A. A., Mathew, B., Aleya, L., Barreto, G. E., Bin-Jumah, M. N., Abdel‐Daim, M. M., & Ashraf, G. M. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116974 · Cited by 70
Han, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67
A New Discovery of MicroRNA-455-3p in Alzheimer’s Disease
Kumar, S., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190583 · Cited by 67
Fyn, a Potential Target for Alzheimer's Disease
Yang, K., Belrose, J. C., Trepanier, C. H., Lei, G., Jackson, M. F., & MacDonald, J. F. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110353 · Cited by 67
Stargardt, A., Gillis, J., Kamphuis, W., Wiemhoefer, A., Kooijman, L., Raspe, M. A., Benckhuijsen, W. E., Drijfhout, J. W., Hol, E. M., & Reits, E. A. (2013) · Aging Cell · doi:10.1111/acel.12074 · Cited by 67
The consequences of mitochondrial amyloid β-peptide in Alzheimer's disease
Muirhead, K. E. A., Borger, E., Aitken, L., Conway, S. J., & Gunn‐Moore, F. J. (2010) · Biochemical Journal · doi:10.1042/bj20091941 · Cited by 68
Identification of BACE2 as an avid ß-amyloid-degrading protease
Abdul‐Hay, S. O., Sahara, T., McBride, M., Kang, D., & Leissring, M. A. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-46 · Cited by 73
Amyloid β-Targeted Metal Complexes for Potential Applications in Alzheimer's Disease
Liu, H., Qu, Y., & Wang, X. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0248 · Cited by 70
Amyloid and Alzheimer's Disease: Inside and Out
Tam, J. H. K., & Pasternak, S. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013408 · Cited by 64
Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy
Pérez-Garmendia, R., & Gevorkian, G. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311050004 · Cited by 65
Yamamoto, K., Ueta, Y., Wang, L., Yamamoto, R., Inoue, N., Inokuchi, K., Aiba, A., Yonekura, H., & Kato, N. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6752-10.2011 · Cited by 69
Sreenivasmurthy, S. G., Liu, J., Song, J., Yang, C., Malampati, S., Wang, Z., Huang, Y., & Li, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020272 · Cited by 67
Chandra, S., & Pahan, K. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190104 · Cited by 68
Autophagy is involved in oligodendroglial precursor-mediated clearance of amyloid peptide
Li, W., Tang, Y., Fan, Z., Meng, Y. J., Yang, G., Luo, J., & Ke, Z. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-27 · Cited by 65
Price, K. A., Varghese, M., Sowa, A., Yuk, F., Brautigam, H., Ehrlich, M. E., & Dickstein, D. L. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-41 · Cited by 67
The functional neurophysiology of the amyloid precursor protein (APP) processing pathway
Randall, A. D., Witton, J., Booth, C., Hynes-Allen, A. M., & Brown, J. T. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.011 · Cited by 66
Metadata
- Authors
- LaFerla, F. M., Green, K. N., & Oddo, S.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- LaFerla, Frank M.
- Venue
- Nature Reviews Neuroscience
- Published
- 2007-07
- Volume
- 8
- Issue
- 7
- Pages
- 499-509
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W1602771322
- Cited by
- 1,942
- References
- 153
- Citations by year
- 2026: 69 · 2025: 74 · 2024: 106 · 2023: 73 · 2022: 87 · 2021: 110 · 2020: 137 · 2019: 122 · 2018: 129 · 2017: 117 · 2016: 119 · 2015: 111 · 2014: 107 · 2013: 96 · 2012: 118
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, intraneuronal amyloid-beta, Alzheimer's disease, amyloid plaques, amyloid-beta production, neuronal pathology, transgenic mouse model
- MeSH terms
- Alzheimer Disease, Animals, Brain, Humans, Intracellular Fluid, Synaptic Transmission, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Extracellular Fluid, Proteasome Endopeptidase Complex, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
